Hollsteen
← Microchip

Total liabilities & equity

Balance – as of period end · $B

QuartersFiscal years

$BTotal liabilities & equity · Q1 FY2016: $4.9B · 10-Q 0000827054-15-000134 filed Aug 6, 2015Total liabilities & equity · Q2 FY2016: $5.8B · 10-Q 0000827054-15-000218 filed Nov 9, 2015Total liabilities & equity · Q3 FY2016: $5.4B · 10-Q 0000827054-16-000265 filed Feb 5, 2016Total liabilities & equity · Q4 FY2016: $5.5B · 10-K 0000827054-17-000098 filed May 30, 2017Total liabilities & equity · Q1 FY2017: $7.4B · 10-Q 0000827054-16-000385 filed Aug 9, 2016Total liabilities & equity · Q2 FY2017: $7.1B · 10-Q 0000827054-16-000472 filed Nov 8, 2016Total liabilities & equity · Q3 FY2017: $7.1B · 10-Q 0000827054-17-000018 filed Feb 8, 2017Total liabilities & equity · Q4 FY2017: $7.7B · 10-K 0001628280-18-006982 filed May 18, 2018Total liabilities & equity · Q1 FY2018: $7.9B · 10-Q 0000827054-17-000132 filed Aug 4, 2017Total liabilities & equity · Q2 FY2018: $8.1B · 10-Q 0000827054-17-000203 filed Nov 7, 2017Total liabilities & equity · Q3 FY2018: $8.1B · 10-Q 0000827054-18-000021 filed Feb 7, 2018Total liabilities & equity · Q4 FY2018: $8.3B · 10-K 0001628280-18-006982 filed May 18, 2018Total liabilities & equity · Q1 FY2019: $19.2B · 10-Q 0000827054-18-000143 filed Aug 9, 2018Total liabilities & equity · Q2 FY2019: $18.7B · 10-Q 0000827054-18-000249 filed Nov 7, 2018Total liabilities & equity · Q3 FY2019: $18.2B · 10-Q 0000827054-19-000018 filed Feb 6, 2019Total liabilities & equity · Q4 FY2019: $18.4B · 10-K 0000827054-19-000143 filed May 30, 2019Total liabilities & equity · Q1 FY2020: $18.2B · 10-Q 0000827054-19-000197 filed Aug 7, 2019Total liabilities & equity · Q2 FY2020: $17.9B · 10-Q 0000827054-19-000288 filed Nov 6, 2019Total liabilities & equity · Q3 FY2020: $17.6B · 10-Q 0000827054-20-000029 filed Feb 4, 2020Total liabilities & equity · Q4 FY2020: $17.4B · 10-K 0000827054-20-000119 filed May 22, 2020Total liabilities & equity · Q1 FY2021: $17.0B · 10-Q 0000827054-20-000186 filed Aug 4, 2020Total liabilities & equity · Q2 FY2021: $16.8B · 10-Q 0000827054-20-000278 filed Nov 5, 2020Total liabilities & equity · Q3 FY2021: $16.6B · 10-Q 0000827054-21-000025 filed Feb 4, 2021Total liabilities & equity · Q4 FY2021: $16.5B · 10-K 0000827054-21-000106 filed May 18, 2021Total liabilities & equity · Q1 FY2022: $16.3B · 10-Q 0000827054-21-000187 filed Aug 3, 2021Total liabilities & equity · Q2 FY2022: $16.2B · 10-Q 0000827054-21-000280 filed Nov 4, 2021Total liabilities & equity · Q3 FY2022: $16.0B · 10-Q 0000827054-22-000025 filed Feb 3, 2022Total liabilities & equity · Q4 FY2022: $16.2B · 10-K 0000827054-22-000094 filed May 20, 2022Total liabilities & equity · Q1 FY2023: $16.2B · 10-Q 0000827054-22-000148 filed Aug 2, 2022Total liabilities & equity · Q2 FY2023: $16.1B · 10-Q 0000827054-22-000193 filed Nov 3, 2022Total liabilities & equity · Q3 FY2023: $16.1B · 10-Q 0000827054-23-000020 filed Feb 2, 2023Total liabilities & equity · Q4 FY2023: $16.4B · 10-K 0000827054-23-000080 filed May 25, 2023Total liabilities & equity · Q1 FY2024: $16.5B · 10-Q 0000827054-23-000132 filed Aug 3, 2023Total liabilities & equity · Q2 FY2024: $16.6B · 10-Q 0000827054-23-000185 filed Nov 2, 2023Total liabilities & equity · Q3 FY2024: $16.1B · 10-Q 0000827054-24-000024 filed Feb 1, 2024Total liabilities & equity · Q4 FY2024: $15.9B · 10-K 0000827054-24-000098 filed May 23, 2024Total liabilities & equity · Q1 FY2025: $15.8B · 10-Q 0000827054-24-000139 filed Aug 1, 2024Total liabilities & equity · Q2 FY2025: $15.6B · 10-Q 0000827054-24-000206 filed Nov 5, 2024Total liabilities & equity · Q3 FY2025: $15.6B · 10-Q 0000827054-25-000019 filed Feb 6, 2025Total liabilities & equity · Q4 FY2025: $15.4B · 10-K 0000827054-25-000077 filed May 23, 2025Total liabilities & equity · Q1 FY2026: $15.0B · 10-Q 0000827054-25-000133 filed Aug 7, 2025Total liabilities & equity · Q2 FY2026: $14.5B · 10-Q 0000827054-25-000183 filed Nov 6, 2025Total liabilities & equity · Q3 FY2026: $14.3B · 10-Q 0000827054-26-000009 filed Feb 5, 2026Total liabilities & equity · Q4 FY2026: $14.4B · 10-K 0000827054-26-000016 filed May 21, 2026Total liabilities & equity · Q1 FY2027: $14.4B · 10-Q 0000827054-26-000038 filed Aug 6, 202616.114.44.919.2Q1 FY2016Q1 FY2027Q3 FY2023
$BTotal liabilities & equity · Q3 FY2022: $16.0B · 10-Q 0000827054-22-000025 filed Feb 3, 2022Total liabilities & equity · Q4 FY2022: $16.2B · 10-K 0000827054-22-000094 filed May 20, 2022Total liabilities & equity · Q1 FY2023: $16.2B · 10-Q 0000827054-22-000148 filed Aug 2, 2022Total liabilities & equity · Q2 FY2023: $16.1B · 10-Q 0000827054-22-000193 filed Nov 3, 2022Total liabilities & equity · Q3 FY2023: $16.1B · 10-Q 0000827054-23-000020 filed Feb 2, 2023Total liabilities & equity · Q4 FY2023: $16.4B · 10-K 0000827054-23-000080 filed May 25, 2023Total liabilities & equity · Q1 FY2024: $16.5B · 10-Q 0000827054-23-000132 filed Aug 3, 2023Total liabilities & equity · Q2 FY2024: $16.6B · 10-Q 0000827054-23-000185 filed Nov 2, 202316.116.616.0Q3 FY2022Q2 FY2024Q3 FY2023
Q3 FY2023
16.1$B
All values (45)
PeriodValue ($B)Status
Q1 FY202714.4reported
Q4 FY202614.4reported
Q3 FY202614.3reported
Q2 FY202614.5reported
Q1 FY202615.0reported
Q4 FY202515.4reported
Q3 FY202515.6reported
Q2 FY202515.6reported
Q1 FY202515.8reported
Q4 FY202415.9reported
Q3 FY202416.1reported
Q2 FY202416.6reported
Q1 FY202416.5reported
Q4 FY202316.4reported
Q3 FY202316.1reported
Q2 FY202316.1reported
Q1 FY202316.2reported
Q4 FY202216.2reported
Q3 FY202216.0reported
Q2 FY202216.2reported
Q1 FY202216.3reported
Q4 FY202116.5reported
Q3 FY202116.6reported
Q2 FY202116.8reported
Q1 FY202117.0reported
Q4 FY202017.4reported
Q3 FY202017.6reported
Q2 FY202017.9reported
Q1 FY202018.2reported
Q4 FY201918.4reported
Q3 FY201918.2reported
Q2 FY201918.7reported
Q1 FY201919.2reported
Q4 FY20188.3reported
Q3 FY20188.1reported
Q2 FY20188.1reported
Q1 FY20187.9reported
Q4 FY20177.7reported
Q3 FY20177.1reported
Q2 FY20177.1reported
Q1 FY20177.4reported
Q4 FY20165.5reported
Q3 FY20165.4reported
Q2 FY20165.8reported
Q1 FY20164.9reported

CSV with all sources · Technical ID: liabilities_and_equity

More metrics for Microchip

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Gross profit by segment

Sources & calculation
Value
$16.1B
Period
Q3 FY2023, ended Dec 31, 2022 · as of Dec 31, 2022 (balance as of date, not a sum)
Source
10-Q, filed Feb 2, 2023 · 0000827054-23-000020
Location
us-gaap:LiabilitiesAndStockholdersEquity
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$16.1BFeb 2, 202310-Q 0000827054-23-000020reported · confidence 1. · current